Development Level

Tbio 17 | 10,625
Tchem 2 | 1,890

IMPC Phenotype

preweaning lethality, complete... 2 | 633
short tibia 2 | 82
abnormal embryo size 1 | 112
decreased caudal vertebrae num... 1 | 49
decreased lumbar vertebrae num... 1 | 62
decreased startle reflex 1 | 48
hydrops fetalis 1 | 22

Disease

Cancer 9 | 2,346
psoriasis 7 | 6,685
Osteoporosis 5 | 259
ovarian cancer 5 | 8,491
Breast cancer 4 | 3,098
Cleft palate 4 | 125
interstitial cystitis 4 | 2,299
osteosarcoma 4 | 7,933
Cleft Lip 3 | 91
Female Urogenital Diseases 3 | 18
cystic fibrosis 3 | 1,670
medulloblastoma, large-cell 3 | 6,234
pilocytic astrocytoma 3 | 3,086
Crohn's disease 2 | 304
Heart conduction disease 2 | 65
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse 2 | 12
Osteoporosis, Juvenile 2 | 4
Parkinson's disease 2 | 364
Tooth agenesis 2 | 38
Uterine Cervical Neoplasm 2 | 21
astrocytoma 2 | 1,493
breast carcinoma 2 | 1,614
chronic rhinosinusitis 2 | 512
colon cancer 2 | 1,475
cutaneous lupus erythematosus 2 | 1,056
ductal carcinoma in situ 2 | 1,745
fibroadenoma 2 | 557
glioblastoma 2 | 5,572
group 3 medulloblastoma 2 | 2,254
invasive ductal carcinoma 2 | 2,950
lung adenocarcinoma 2 | 2,714
lung carcinoma 2 | 2,844
non primary Sjogren syndrome sicca 2 | 840
non-small cell lung cancer 2 | 2,798
pancreatic cancer 2 | 2,300
pediatric high grade glioma 2 | 2,712
posterior fossa group A ependymoma 2 | 1,511
sonic hedgehog group medulloblastoma 2 | 1,482
ulcerative colitis 2 | 2,087
AMYOTROPHIC LATERAL SCLEROSIS 1 1 | 49
Adenoid Cystic Carcinoma 1 | 99
Alexithymia 1 | 14
Amenorrhea 1 | 60
Androgenic alopecia 1 | 10
Atopic dermatitis 1 | 944
Atrial Fibrillation 1 | 110
Autistic Disorder 1 | 320
Autosomal recessive hypohidrotic ectodermal dysplasia 1 | 3
Barrett's esophagus 1 | 185
Celiac disease 1 | 112
Coffin-Siris syndrome 1 | 17
Congenital diaphragmatic hernia 1 | 44
Connective tissue disease 1 | 59
Dwarfism 1 | 6
Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive 1 | 3
Electrocardiogram: P-R interval 1 | 9
Epithelial ovarian cancer 1 | 19
Extratemporal epilepsy 1 | 6
Fibroid Tumor 1 | 6
Focal dermal hypoplasia 1 | 9
Frontotemporal dementia 1 | 47
Genitourinary Neoplasms 1 | 3
Hyperandrogenism 1 | 32
Hypohidrotic ectodermal dysplasia 1 | 14
Hypotrichosis 1 | 29
Infertility 1 | 163
Kidney Diseases 1 | 86
Kidney disease 1 | 397
Lung Neoplasms 1 | 171
Mammary Neoplasms 1 | 410
Motor neuron disease 1 | 39
Neoplastic Cell Transformation 1 | 81
OSTEOGENESIS IMPERFECTA, TYPE XV 1 | 1
Osteogenesis Imperfecta, Type 15 1 | 1
Osteogenesis imperfecta 1 | 34
Osteogenesis imperfecta 15 1 | 1
Osteogenesis imperfecta type III (disorder) 1 | 11
Osteogenesis imperfecta type IV (disorder) 1 | 10
Palmoplantar keratosis 1 | 36
Parkinson Disease 1 | 105
Peripheral Neuropathy 1 | 303
Pneumothorax 1 | 17
Premature ovarian failure 1 | 64
Renal agenesis 1 | 25
Reperfusion Injury 1 | 84
Robinow syndrome 1 | 12
Robinow syndrome, autosomal dominant 1 1 | 1
Salivary Gland Neoplasms 1 | 45
Scheuermann's disease 1 | 10
Sclerosteosis 1 | 9
Synostosis 1 | 18
atypical teratoid/rhabdoid tumor 1 | 1,095
autosomal dominant Robinow syndrome 1 1 | 2
facioscapulohumeral dystrophy 1 | 286
head and neck cancer 1 | 270
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
nail-patella syndrome 1 | 16
osteogenesis imperfecta type 3 1 | 11
osteogenesis imperfecta type 4 1 | 10
tuberculosis and treatment for 3 months 1 | 327

Tissue

Digestive Tract 19 | 18,472
Endocrine System 19 | 18,511
Female tissues 19 | 18,646
Male tissues 19 | 17,968
Nervous System 19 | 18,560
Respiratory system 19 | 17,483
Skin and soft tissues 19 | 18,114
Urinary Tract 19 | 18,443
Blood and immune system 18 | 17,994
Liver and Pancreas 18 | 18,135
Cardiovascular System 17 | 17,957

Target Family

Non-IDG 19 | 11,969

PathwayCommons: inoh Pathway

Wnt secretory pathway (Canonic... 19 | 19
Drosophila Toll-like receptor ... 235 | 235
Heterotrimeric GPCR signaling ... 235 | 235
Heterotrimeric GPCR signaling ... 233 | 233
Heterotrimeric GPCR signaling ... 224 | 224
Heterotrimeric GTP-binding pro... 224 | 224
Heterotrimeric GPCR signaling ... 223 | 223
Heterotrimeric GTP-binding pro... 223 | 223
VEGF signaling pathway ( VEGF ... 183 | 183
Positive regulation of (Transc... 178 | 178
AKT(PKB)-Bad signaling ( EPO s... 173 | 173
AKT(PKB)-Bad signaling ( IL-7 ... 173 | 173
Integrin signaling pathway ( I... 123 | 123
JAK-STAT pathway and regulatio... 96 | 96
Purine nucleotides and Nucleos... 85 | 85
B cell receptor signaling path... 60 | 60
Tryptophan degradation ( Trypt... 60 | 60
Insulin receptor signaling (Ma... 58 | 58
Canonical Wnt signaling pathwa... 56 | 56
Canonical Wnt signaling pathwa... 56 | 56
Canonical Wnt signaling pathwa... 56 | 56
Canonical Wnt signaling pathwa... 56 | 56
Canonical Wnt signaling pathwa... 56 | 56
Insulin receptor signaling ( I... 55 | 55
TGF-beta_super_family_signalin... 51 | 51
Mammalian Wnt signaling pathwa... 49 | 49
Signaling with Wnt (Canonical)... 47 | 47
Signaling with Wnt (Canonical)... 47 | 47
Signaling with Wnt (Canonical)... 47 | 47
Signaling with Wnt (Canonical)... 47 | 47
Signaling with Wnt (Canonical)... 47 | 47
Signaling with Wnt (Mammal) ( ... 47 | 47
TGF beta receptor complex degr... 47 | 47
Heterotrimeric GPCR signaling ... 45 | 45
FGF signaling pathway ( FGF si... 44 | 44
T cell receptor signaling path... 43 | 43
Inositol phosphate metabolism ... 42 | 42
TGF beta receptor I degradatio... 42 | 42
CD4 T cell receptor signaling ... 40 | 40
Cytokine receptor degradation ... 40 | 40
Negative regulation of (Phosph... 40 | 40
T cell receptor signaling (PLC... 40 | 40
SnoN degradation signaling ( T... 37 | 37
T cell receptor signaling (PLC... 37 | 37
G alpha i GDP-GTP exchange sig... 36 | 36
G alpha i GDP-GTP exchange sig... 36 | 36
G alpha s GDP-GTP exchange sig... 35 | 35
G alpha s GDP-GTP exchange sig... 35 | 35
G alpha s GDP-GTP exchange sig... 35 | 35
BMP signaling pathway ( TGF-be... 34 | 34
HGF signaling pathway ( HGF si... 30 | 30
Pyrimidine Nucleotides and Nuc... 30 | 30
Arginine and Proline metabolis... 29 | 29
PDGF signaling pathway (Mammal... 29 | 29
Xenopus axis formation Wnt sig... 28 | 28
Glycine and Serine metabolism ... 27 | 27
IGF1 signaling pathway ( IGF1 ... 27 | 27
Stabilization and accumulation... 24 | 24
Stabilization and accumulation... 24 | 24
Stabilization and accumulation... 24 | 24
Stabilization and accumulation... 24 | 24
Stabilization and accumulation... 24 | 24
Stabilization and accumulation... 24 | 24
Prostaglandin and Leukotriene ... 22 | 22
Fas signaling pathway ( Fas si... 21 | 21
Negative regulation of (G alph... 21 | 21
Negative regulation of (G alph... 21 | 21
Negative regulation of (transc... 21 | 21
FGF8 signaling pathway(Mouse) ... 20 | 20
Negative regulation of (G alph... 20 | 20
Negative regulation of (G alph... 20 | 20
Negative regulation of heterot... 20 | 20
Canonical Notch signaling path... 19 | 19
IFN alpha signaling pathway((J... 19 | 19
Signaling with Wnt (Xenopus) (... 19 | 19
Toll-like receptor signaling p... 19 | 19
Wnt secretory pathway (Canonic... 19 | 19
Wnt secretory pathway (Canonic... 19 | 19
Wnt secretory pathway (Canonic... 19 | 19
Wnt secretory pathway (Canonic... 19 | 19
Wnt secretory pathway (Mammal)... 19 | 19
FGF8 signaling pathway(Xenopus... 18 | 18
Heterotrimeric GPCR signaling ... 18 | 18
Histidine degradation ( Histid... 18 | 18
IFN alpha signaling pathway(JA... 18 | 18
Nicotinate and Nicotinamide me... 18 | 18
PKA activation signaling ( GPC... 18 | 18
PKA activation signaling ( GPC... 18 | 18
Ci/Gli processing signaling ( ... 17 | 17
ERK cascade ( FGF8 signaling (... 17 | 17
ERK cascade ( FGF8 signaling (... 17 | 17
IFN alpha signaling pathway(JA... 17 | 17
IFN alpha signaling pathway(JA... 17 | 17
Folate metabolism ( Folate met... 16 | 16
JNK cascade ( IL-1 signaling p... 16 | 16
Methionine and Cysteine metabo... 16 | 16
NGF signaling pathway ( NGF si... 16 | 16
Valine,Leucine and Isoleucine ... 16 | 16
p38 cascade ( IL-1 signaling p... 16 | 16
IL-1_signaling(through_IKK-NFk... 15 | 15

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Proto-oncogene Wnt-1 WNT1 Tbio Non-IDG -2.73870 492.7 294
Protein Wnt-8a WNT8A Tbio Non-IDG -1.27941 17.4 113
Protein Wnt-5b WNT5B Tbio Non-IDG -1.59245 37.3 141
Protein Wnt-2b WNT2B Tbio Non-IDG -1.72177 53.4 146
Protein Wnt-8b WNT8B Tbio Non-IDG -1.33704 19.1 144
Protein Wnt-11 WNT11 Tbio Non-IDG -2.06036 113.7 91
Protein Wnt-9a WNT9A Tbio Non-IDG -1.37333 24.2 120
Protein Wnt-9b WNT9B Tbio Non-IDG -1.41107 25.2 89
Protein Wnt-2 WNT2 Tbio Non-IDG -2.25852 155.5 156
Protein Wnt-7b WNT7B Tbio Non-IDG -1.73762 49.7 38